Global Anti-infective Drugs Markets to 2026: Market Size & Share, Application Analysis, Growth Trends, Key Players, and Competitive Strategies

DUBLIN, Sept. 18, 2018 /PRNewswire/ --

The "Global Anti-infective Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

The global anti-infective drugs market was valued at US$ 114,882.2 Mn in 2017 and expected to reach US$ 168,628.1 Mn by 2026, expanding at a CAGR of 4.3% from 2018 to 2026.

Growing prevalence of infectious diseases such as malaria, HIV, Ebola virus infection and so on has brought several changes in the healthcare environment worldwide. Growing awareness in the general population and healthcare professionals, and reimbursements to infection treatment has played a critical role in determining the trends in the anti-infective drugs market.

Furthermore, associations and welfare bodies such as the WHO are also actively seeking to enhance awareness regarding infectious diseases. Introduction of novel therapeutics with better efficacy, and healthy drug pipeline will open better avenues in the market.

Among the considered drugs such as anti-bacterials, anti-virals, and anti-fungals; anti-bacterial drugs segment dominated the global anti-infectives market in 2017. The dominance of anti-bacterials segment is mainly attributed to higher preference as the first line of treatment, and greater acceptance, popularity and accessibility. Introduction of combination drugs for treatment and prevention of spread of serious infections will further assist in augmenting the market growth.

Additionally, it is anticipated that the anti-viral drugs will undergo the fastest growth in the market during the forecast period, due to high prices of anti-virals and introduction of stronger medications in the market.

Geographically, North America dominates the global anti-infective drugs market high prevalence of infections across all age groups. Impressive accessibility to infection treatments and existence evolved reimbursement system are attributed to the dominant position of North America in the global market.

On the other hand, Asia Pacific will witness the fastest market growth during the forecast period. Rapid evolution of healthcare infrastructure, high unmet needs for novel drugs and growing awareness in patient pool and healthcare professionals support the rapid growth of this market.

The global anti-infective drugs market is highly competitive and fragmented in nature. The presence of generic drugs is significant in the market with stronghold of local players in this segment.

Key Highlights

• Growing birth rate and life expectancy to increase the incidence of infective diseases
• Poor living conditions in low- and middle-income countries have further increased the incidence of infections that may prove fatal to the patients if left untreated
• Increasing influx of novel and combination drugs that act against drug resistance
• Entry of major market players in the emerging regions and Asia Pacific and Middle East & Africa

Key Topics Covered

Chapter 1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Anti-infective Drugs Market Portraiture
2.2. Global Anti-infective Drugs Market, by Type, 2017 (US$ Mn)
2.3. Global Anti-infective Drugs Market, by Range, 2017 (US$ Mn)
2.4. Global Anti-infective Drugs Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Anti-infective Drugs Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Anti-infective Drugs Market, by Key Players, 2017

Chapter 4. Global Anti-infective Drugs Market, by Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Anti-bacterials
4.3. Anti-virals
4.4. Anti-fungals
4.5. Others (Antihelmethics, Antiprotozoals, etc.)

Chapter 5. Global Anti-infective Drugs Market, by Range, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Broad Spectrum
5.3. Narrow Spectrum

Chapter 6. Global Anti-infective Drugs Market, by Geography, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Europe Anti-infective Drugs Market, 2016-2026 (US$ Mn)
6.3. Asia Pacific Anti-infective Drugs Market, 2016-2026 (US$ Mn)
6.4. Latin America Anti-infective Drugs Market, 2016-2026 (US$ Mn)
6.5. Middle East & Africa Anti-infective Drugs Market, 2016-2026 (US$ Mn)

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Allergen plc
7.3. Astellas Pharma Inc.
7.4. AstraZeneca Plc
7.5. Bayer AG
7.6. Bristol-Myers Squibb Co.
7.7. Boehringer Ingelheim
7.8. F. Hoffman-La Roche Ltd.
7.9. Gilead Sciences
7.10. GlaxoSmithKline Plc
7.11. Johnson and Johnson
7.12. Merck & Co., Inc.
7.13. Pfizer, Inc.
7.14. Sanofi-Aventis SA
7.15. Novartis AG

For more information about this report visit https://www.researchandmarkets.com/research/t7lrqm/global?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets